Literature DB >> 11101573

Antigenic diversity of Haemophilus somnus lipooligosaccharide: phase-variable accessibility of the phosphorylcholine epitope.

M D Howard1, A D Cox, J N Weiser, G G Schurig, T J Inzana.   

Abstract

The lipooligosaccharide (LOS) of Haemophilus somnus undergoes antigenic phase variation, which may facilitate evasion from the bovine host immune response and/or colonization and dissemination. However, LOS antigenic diversity in H. somnus has not been adequately investigated. In this study, monoclonal antibodies (MAbs) specific to various LOS epitopes were used to investigate antigenic variation and stability in LOS from H. somnus strains and phase variants. Clinical isolates of H. somnus exhibited intrastrain, as well as interstrain, antigenic heterogeneity in LOS when probed with MAbs to outer core oligosaccharide epitopes in an enzyme-linked immunosorbent assay (ELISA). However, epitopes reactive with MAbs directed predominately to the inner core heptose region were highly conserved. At least one epitope, which was expressed in few strains, was identified. One LOS component affected by phase variation was identified as phosphorylcholine (PCho), which is linked to the primary glucose residue. Inhibition ELISA, immunoblotting, and electrospray-mass spectrometry were used to confirm that MAb 5F5.9 recognized PCho. LOS reactivity with MAb 5F5.9 was associated with loss of most of the outer core oligosaccharide, indicating that reactivity with PCho was affected by phase variation of the glucose residues in this region. Our results indicate that outer core epitopes of H. somnus LOS exhibit a high degree of random, phase-variable antigenic heterogeneity and that such heterogeneity must be considered in the design of vaccines and diagnostic tests.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101573      PMCID: PMC87614     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

Review 1.  PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells.

Authors:  D R Cundell; C Gerard; I Idanpaan-Heikkila; E I Tuomanen; N P Gerard
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

2.  Development of a defined medium for Haemophilus somnus isolated from cattle.

Authors:  T J Inzana; L B Corbeil
Journal:  Am J Vet Res       Date:  1987-03       Impact factor: 1.156

3.  Use of a bilayer stacking gel to improve resolution of lipopolysaccharides and lipooligosaccharides in polyacrylamide gels.

Authors:  T J Inzana; M A Apicella
Journal:  Electrophoresis       Date:  1999-03       Impact factor: 3.535

4.  Vaccination of cattle against experimentally induced thromboembolic meningoencephalitis with a Haemophilus somnus bacterin.

Authors:  L R Stephens; P B Little; J D Humphrey; B N Wilkie; D A Barnum
Journal:  Am J Vet Res       Date:  1982-08       Impact factor: 1.156

5.  Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.

Authors:  H J Ahmed; A Frisk; J E Månsson; E K Schweda; T Lagergård
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed by a capsule-deficient strain of Haemophilus influenzae Rd.

Authors:  A Risberg; H Masoud; A Martin; J C Richards; E R Moxon; E K Schweda
Journal:  Eur J Biochem       Date:  1999-04

7.  Structural determination of oligosaccharides derived from lipooligosaccharide of Neisseria gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods.

Authors:  R Yamasaki; B E Bacon; W Nasholds; H Schneider; J M Griffiss
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

8.  Purification and characterization of lipooligosaccharides from four strains of "Haemophilus somnus".

Authors:  T J Inzana; B Iritani; R P Gogolewski; S A Kania; L B Corbeil
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  Structural analysis of the phase-variable lipooligosaccharide from Haemophilus somnus strain 738.

Authors:  A D Cox; M D Howard; J R Brisson; M van der Zwan; P Thibault; M B Perry; T J Inzana
Journal:  Eur J Biochem       Date:  1998-04-15

10.  Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein.

Authors:  J N Weiser; N Pan; K L McGowan; D Musher; A Martin; J Richards
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

View more
  10 in total

1.  Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.

Authors:  Wei-chang Shen; Xu Wang; Wei-ting Qin; Xue-feng Qiu; Bing-wei Sun
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

2.  Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation.

Authors:  Christopher J Kuckleburg; Shaadi F Elswaifi; Thomas J Inzana; Charles J Czuprynski
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  Differential involvement of toll-like receptors 2 and 4 in the host response to acute respiratory infections with wild-type and mutant Haemophilus influenzae strains.

Authors:  Eva Lorenz; Diana C Chemotti; Alice L Jiang; Letitia D McDougal
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Platelet activation by Histophilus somni and its lipooligosaccharide induces endothelial cell proinflammatory responses and platelet internalization.

Authors:  Christopher J Kuckleburg; Dave J McClenahan; Charles J Czuprynski
Journal:  Shock       Date:  2008-02       Impact factor: 3.454

5.  Molecular characterization of phosphorylcholine expression on the lipooligosaccharide of Histophilus somni.

Authors:  Shaadi F Elswaifi; Frank St Michael; Avula Sreenivas; Andrew Cox; George M Carman; Thomas J Inzana
Journal:  Microb Pathog       Date:  2009-08-12       Impact factor: 3.738

6.  Characterization and comparison of biofilm development by pathogenic and commensal isolates of Histophilus somni.

Authors:  Indra Sandal; Wenzhou Hong; W Edward Swords; Thomas J Inzana
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

7.  Incorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.

Authors:  Thomas J Inzana; Gretchen Glindemann; Andrew D Cox; Warren Wakarchuk; Michael D Howard
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  The role of lipooligosaccharide phosphorylcholine in colonization and pathogenesis of Histophilus somni in cattle.

Authors:  Shaadi F Elswaifi; William K Scarratt; Thomas J Inzana
Journal:  Vet Res       Date:  2012-06-07       Impact factor: 3.683

9.  Identification, structure, and characterization of an exopolysaccharide produced by Histophilus somni during biofilm formation.

Authors:  Indra Sandal; Thomas J Inzana; Antonio Molinaro; Christina De Castro; Jian Q Shao; Michael A Apicella; Andrew D Cox; Frank St Michael; Gretchen Berg
Journal:  BMC Microbiol       Date:  2011-08-19       Impact factor: 3.605

10.  Histophilus somni causes extracellular trap formation by bovine neutrophils and macrophages.

Authors:  Katrina M Hellenbrand; Katelyn M Forsythe; Jose J Rivera-Rivas; Charles J Czuprynski; Nicole A Aulik
Journal:  Microb Pathog       Date:  2012-09-27       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.